Title(s):
A032001 MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab vs maintenance avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer (NCT05092958)
Investigator(s): Judy Tsai, MD
Contact Information: McDowell Cancer Research 330.344.6348
Title(s):
NRG-GU010 Parallel Phase III Randomized Trials of Genomic Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE) (NCT#05050084)
Investigator(s): Ashok Ramalingam, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Referral to: ProstateCancerPromise.org
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
NRG-GU008 Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *Intensifying treatment for Node positive prostate cancer by Varying the hormonal Therapy
Investigator(s): Ashok Ramalingam, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
NRG-GU009 Parallel Phase III Randomized Trials For High Risk Prostate Cancer Evaluating De-Intensification For Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (Predict-RT*)
Investigator(s): Ashok Ramalingam, MD
Contact Information: McDowell Cancer Research 330.344.6348
